BlackRock, Inc. - 30 Sep 2025 SCHEDULE 13G/A Report for Lexeo Therapeutics, Inc. Common Stock (LXEO)

Filing Manager: BlackRock, Inc.
Reporting Manager: BlackRock, Inc.
Security: Lexeo Therapeutics, Inc. Common Stock
Symbol: LXEO
Shares outstanding: 54,211,100 shares
Disclosed Ownership: 2,168,444 shares
Ownership: 4%
Form type: SCHEDULE 13G/A
Filing time: 17 Oct 2025, 18:13:44 UTC
Date of event: 30 Sep 2025
Previous filing: 04 Feb 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BlackRock, Inc.	4%	2,168,444	2,129,602	0	Spencer Fleming	Managing Director